| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 1994 (ast)
- наукова стаття, опублікована в березні 1994 (uk)
- مقالة علمية نشرت في مارس 1994 (ar)
- scientific article published on March 1994 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| cites work
| |
| cites work
| |
| author name string
| |
| author name string
| - J S Youngner
- P Whitaker-Dowling
- R F Betts
- J J Treanor
|
| rdfs:label
| - Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans. (nl)
- Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans (en)
- Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans (ast)
|
| skos:prefLabel
| - Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans. (nl)
- Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans (en)
- Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans (ast)
|
| name
| - Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans. (nl)
- Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans (en)
- Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans (ast)
|
| title
| |
| title
| - Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1128/JCM.32.3.750-754.1994
|
| PMCID
| |
| PMCID
| |
| is about
of | |
| is cites work
of | - Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial
- Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
- Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review
- Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
- The threat of avian influenza A (H5N1). Part IV: Development of vaccines.
- Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire
- Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain
- The role of live influenza vaccines in children
- Multi-scale modeling for the transmission of influenza and the evaluation of interventions toward it.
- Cold-attenuated live influenza vaccines, a risk-benefit assessment
- Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model
- Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies
- An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection
- Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine
- Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1
- Are placebo controls necessary in controlled human infection trials for vaccines?
- The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics.
- The potential for a controlled human infection platform in Singapore
- Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus.
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)